425: Strive CRO Posts Merger Update, Cautions on Risks

Strive's Chief Risk Officer posted a communication on X.com regarding the proposed business combination with Semler Scientific, emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc.
• The communication was posted on X.com by Jeff Walton, Strive's Chief Risk Officer, on December 4, 2025.
• It includes a cautionary statement about forward-looking statements concerning the proposed transaction, its strategic and financial benefits, timing, and integration.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings before making voting or investment decisions.
• Information about participants in the solicitation of proxies from Semler Scientific stockholders is detailed, including directors, executive officers, and their security holdings.

Sentiment

Score: 4

Explanation: The filing is primarily a procedural communication about a proposed merger, heavily emphasizing the numerous risks and uncertainties associated with forward-looking statements. While a merger itself can be positive, the document's focus on potential negative outcomes and cautionary language leads to a neutral-to-slightly-negative sentiment.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• The filing indicates progress towards the business combination by detailing required disclosures and investor information.

Negatives

• The filing highlights numerous risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could occur.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions not being met.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing discusses the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, it heavily qualifies these as forward-looking statements subject to significant risks and uncertainties.

Management Comments

• "Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied by such forward-looking statements."
• "Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that the actual results of Strive or Semler Scientific will not differ materially from any projected future results expressed or implied by such forward-looking statements."
• "Investors are cautioned not to rely too heavily on any such forward-looking statements."

Industry Context

The filing mentions "risks associated with Bitcoin and other digital assets" and "implementation of Bitcoin treasury strategies," which suggests Strive or the combined entity may be involved in or exposed to the digital asset industry, a growing trend for some companies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Customers of Strive and Semler Scientific may have adverse reactions to the merger.
• Business and employee relationships could change as a result of the announcement or completion of the transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets